What is Responsive Neurostimulation (RNS)?
The word “responsive” means this device is smart, it monitors what’s happening in the brain and reacts in real time. The RNS System is a small, programmable device that continuously monitors brain activity. When it detects unusual electrical patterns that might lead to a seizure, it automatically sends tiny, gentle pulses of stimulation to interrupt that activity. RNS is different from VNS and DBS, because it provides continuous monitoring and responsive, on-demand stimulation upon detection of abnormal activity.
RNS responses happen incredibly fast (within milliseconds), with the goal of helping the brain return to a normal rhythm on its own. The brain data collected by the RNS System can also be shared with doctors to help guide treatment decisions and contribute to ongoing research.
One thing to know is that managing the RNS System is the most involved of the three neurostimulation options. It requires daily data uploads using a home monitor, as well as regular clinic visits for programming adjustments. This routine can take some getting used to.
How is the surgery done?
The RNS device is a small, metal-encased, battery-powered unit that is surgically placed directly into the skull. Here’s what that process looks like:
- A small section of the skull (called a craniectomy) is carefully removed to create a space where the neurostimulator can sit flush with the head. It may involve prior invasive intracranial monitoring, such as stereo EEG.
- Up to four electrode leads (thin wires) can be placed into specific areas of the brain, with two connected to the device right away.
- If needed, additional leads can be connected during a later procedure.
- Unlike some other devices, no wiring runs down to the chest, which keeps the procedure more contained to the head.
The current RNS model has a median battery life of about 10.8 years. When the battery eventually needs replacing, it’s done through a minor outpatient procedure, during which only the device itself is swapped out, not the leads.
How does RNS work for LGS?
RNS was originally developed for focal epilepsy (seizures that start in one specific area of the brain). For LGS, which involves more widespread brain activity, doctors adapt the approach by targeting key “hubs” in the brain’s network. The most common target for LGS is the Centromedian Thalamic Nucleus, a region that plays a role in coordinating brain signals. Stimulating this area may help block the spread of the types of generalized seizures seen in LGS.
While RNS is still a newer approach for LGS, the available research is limited but encouraging. In 37 mostly pediatric patients, about 60% had their seizures reduced by at least half, and some improved even more. ASM reduction occurred in 10% of patients. Results varied from person to person, which reflects just how individualized epilepsy treatment can be. The treatment was generally safe, with one study noted primarily implant-related infection (13%). Researchers and clinicians continue to learn more with each patient, and the field is moving forward.
Who might be a candidate?
RNS is FDA-approved for adults with focal epilepsy. For LGS specifically, its use is currently considered investigational (sometimes called “off-label”), meaning it’s still being studied. The RNS System LGS Feasibility Study (no longer recruiting) is specifically looking at the safety and effectiveness of RNS for LGS patients aged 12 and older.
As always, every individual with LGS and their family is different. Talk with your epilepsy team to understand whether RNS might be worth exploring for your loved one.
Additional Resources
The information here is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. The content provided is for informational purposes only. LGS Foundation is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options.
Updated 08/14/26 (KK)